Screener
Xenon Pharmaceuticals XENE Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent.
The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338244
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total assets | $1,295,772 | $633,163 |
| Liabilities and shareholders’ equity | ||
| Current liabilities: | ||
| Accounts payable and accrued liabilities (note 7) | $43,671 | $40,260 |
| Operating lease liability (note 6) | 1,338 | 1,532 |
| Total current liabilities | 45,009 | 41,792 |
| Operating lease liability, long-term (note 6) | 5,080 | 6,412 |
| Other liabilities, long-term | 3,287 | 3,199 |
Item 1. Financial Statements
FAQ
- What is Xenon Pharmaceuticals's accounts payable?
- Xenon Pharmaceuticals (XENE) reported accounts payable of $43.67M in Q2 2026.
- How has Xenon Pharmaceuticals's accounts payable changed year-over-year?
- Xenon Pharmaceuticals's accounts payable increased by 38.3% year-over-year, from $31.59M to $43.67M.
- What is the long-term trend for Xenon Pharmaceuticals's accounts payable?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's accounts payable has grown at a 29.9% compound annual growth rate (CAGR), from $10.87M to $40.26M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Xenon Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude